75
Participants
Start Date
November 1, 2024
Primary Completion Date
February 1, 2027
Study Completion Date
June 30, 2027
Reduced dose of cyclophosphamide combined with standard immunosuppressive therapy
Severe aplastic anemia patients will receive a daily dose of Anti-lymphocyte globulin (25mg/kg) for the initial five days at the beginning of the treatment. Cyclosporine will be administered daily at a dosage of 3-5mg/kg. Herombopag will be administered daily at a dosage of 15mg starting from the first day of treatment and continuing for a duration of six months. Cyclophosphamide (20mg/kg) will be administered on days 15-16.
RECRUITING
Red Blood Cell Disorders Center and Regenerative Medicine Center, Tianjin
Institute of Hematology & Blood Diseases Hospital, China
OTHER